11 May, 2023
EFPIA Japan

EFPIA Japan Patient Organization Support Program “PASE”
The 6th PASE AWARD Starts to Call for Applications,
Expanding the Eligibility to Unincorporated Organizations
TOKYO – 11 May 2023- The European Federation of Pharmaceutical Industries andAssociations Japan (EFPIA Japan, Chair: Takahiko Iwaya) is pleased to announce that it has
started to call for entry to the 6th PASE AWARD (Patient Advocacy Support by EFPIA Japan)
today. The PASE AWARD was created by EFPIA Japan in 2017 as a means to further improvethe medical environment for patients by encouraging patient advocacy activities in Japan andhaving their voices appropriately reflected in the healthcare system.
In the past, the PASE AWARD was intended for officially registered non-profit patientorganizations such as incorporated associations, foundations, and non-profit organizations. Thisyear, EFPIA Japan has expanded the scope of applications to unincorporated patientorganizations and welcomes activity plans that meet the objectives of the AWARD. After theprimary review of documents submitted and the final review based on presentations by theapplicants, EFPIA Japan will select activities that contribute to improving patient health andQuality of Life. It will provide a grant of 500,000 yen to Grand Prize winners (up to twoorganizations) and 150,000 yen to Honour Award winners.
In the past five years, a total of 86 organizations submitted a wide range of activity plans throughthe PASE AWARD, and EFPIA Japan provided a total of 6.6 million yen in grants to nineorganizations for the Grand Prize and 16 organizations for the Honour Award. Last year, under
the theme of "Activities led by patient organizations for realization of patients’ better medicaltreatment and lives under the New Normal", EFPIA Japan presented the Grand Prize to theSpecified Non-profit Corporation ‘Kibounokai (Hope)’ for its program to create an educational
brochure on gastric cancer.
Through the grant provided by the PASE AWARD, ‘Kibounokai’ plans to create a booklet toassist employment for people with diseases. This booklet will be based on the series of video
contents "Understanding Gastric Cancer through Patient Journey” which provides an accurate
understanding of gastric cancer and the basis for treatment choices. The organization plans todisseminate the information in both video and booklet formats.

EFPIA JapanTokyo Opera City Tower, 3-20-2, Nishi Shinjuku, Shinjuku-ku, Tokyo, Japan

The 6th PASE AWARD - Overview of Application Guidelines(Please see here for detailed application requirements (Japanese only))■ Theme: improving patient health and Quality of Life
1. Qualification Requirements① Patient organization working for patients in Japan② Have a specific plan for activities utilizing the grant (including how the grant will be used)③ Able to submit "information required for application" described in the application guidelines④ Have a willingness to disseminate the results of the activity utilizing the grant (permission topost on EFPIA Japan’s website, notification and reporting on the patient advocacy group’sown and other websites)
2. Period of conducting activities① Conduct activities using the grant from the day of receiving the award to October 15, 2024
② Submit an activity report (two A4 pages) to the EFPIA Japan Secretariat by the end of October
2024
3. Requirements of the award-winning organizations
Attend the award ceremony on EFPIA Day (a media seminar scheduled to be held in early October
2023. (There may be media interviews.)4. Use of grants① Organizations that win the Grand Prize must use the grant in their activity plan at the time ofapplication.
② Organizations receiving the Honour Award are not limited to the activity plan at the time ofapplication but must use the grant for activities with clear objectives and submit a report on
the implementation of their activities.
5. Application method
Please refer to the URL below for the application method and send the necessary documents tothe EFPIA Japan PASE AWARD Secretariat (paseaward@cocoknots.co.jp) by email as PDF filesby July 7, 2023.
The PASE AWARD application requirements can be found on the PASE AWARD page of theEFPIA website. http://www.efpia.jp/pase/index.html

EFPIA JapanTokyo Opera City Tower, 3-20-2, Nishi Shinjuku, Shinjuku-ku, Tokyo, Japan

About the EFPIA Japan Patient Organization Support Program “PASE”
EFPIA Japan works with patients to support opportunities and activities that address patientneeds and policy proposals. The PASE (Patient Advocacy Support by EFPIA Japan) AWARD
was created by EFPIA Japan in 2017 as a means to more directly carry out its patient-centricmission to support patient organizations and promote the development of patient advocacy inJapan.
In the 5th PASE AWARD held last year, we provided a total of 1.1 million yen to 1 organization
for the Grand Prize and 4 organizations for the Honour Award, which were selected from the 11organizations that applied.
Please see the link for more information. http://efpia.jp/link/(JPN)5thPASE%20AWARD_Final.pdf
About EFPIA Japan (http://efpia.jp/)
Established in April 2002, EFPIA Japan represents 23 R&D-based European pharmaceuticalcompanies operating in Japan. In 2021, combined sales from the member companies accountedfor roughly 26% of the pharmaceutical market in Japan. The mission of EFPIA Japan is to“Contribute to healthcare and patients in Japan through the early introduction of innovative
medicines and vaccines”. EFPIA Japan aims to strengthen dialogue with decision-makers inorder to improve Japanese healthcare for all.
About EFPIA (European Federation of Pharmaceutical Industries and Associations)(http://www.efpia.eu)
The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents thebiopharmaceutical industry operating in Europe. Through its direct membership of 37 nationalassociations, 38 leading pharmaceutical companies, and a growing number of small andmedium sized enterprises (SMEs), EFPIA’s mission is to create a collaborative environment thatenables our members to innovate, discover, develop, and deliver new therapies and vaccines
for people across Europe, as well as contribute to the European economy.
Contact:
Hitoshi Fujita
EFPIA Japan Communications Committee〒105-6333
1-23-1 Toranomon 1, Minato-ku, Tokyo
Toranomon Hills Mori Tower
Novartis Pharma K.K.
TEL: 090-9837-4326
Mail: hitoshi.fujita@novartis.com

Naomi Sakai
In charge of PASE, EFPIA Japan PatientCommittee〒141-6017
2-1-1 Osaki 2, Shinagawa-ku, Tokyo
ThinkPark Tower
Nippon Boehringer Ingelheim Co., Ltd.
TEL: 03-6417-2489
Mail: naomi.sakai@boehringer-ingelheim.com

EFPIA JapanTokyo Opera City Tower, 3-20-2, Nishi Shinjuku, Shinjuku-ku, Tokyo, Japan